The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
125255001 12525500 1 I 20160622 20160704 20160704 PER US-ASTRAZENECA-2016SE69253 ASTRAZENECA 0.00 M Y 81.60000 KG 20160705 US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
125255001 12525500 1 PS BYETTA EXENATIDE 1 Subcutaneous 22200 10 UG SOLUTION FOR INJECTION IN PRE-FILLED PEN BID
125255001 12525500 2 SS LISINOPRIL AND HYDROCHLOROTHIAZIDE HYDROCHLOROTHIAZIDELISINOPRIL 1 Oral 10/12.5 MG, DAILY 0 TABLET
125255001 12525500 3 SS METOPROLOL SUCCINATE. METOPROLOL SUCCINATE 1 Oral 0 .5 DF MODIFIED-RELEASE TABLET QD
125255001 12525500 4 C WAFARIN SODIUM 2 Unknown 0 5 MG QD
125255001 12525500 5 C PIOGLITAZONE. PIOGLITAZONE 1 Unknown 0 30 MG QD
125255001 12525500 6 C NEFAZODONE HCL 2 Unknown 150.0MG UNKNOWN 0 150 MG
125255001 12525500 7 C METFORMIN METFORMIN HYDROCHLORIDE 1 Unknown 850 MG 0
125255001 12525500 8 C MEGA RED FISH OIL 2 Unknown 0 350 MG QD
125255001 12525500 9 C GLIPIZIDE. GLIPIZIDE 1 Unknown 0 35 MG QD
125255001 12525500 10 C DHEA PRASTERONE 1 Unknown 0 50 MG QD
125255001 12525500 11 C VITAMIN D3 CHOLECALCIFEROL 1 Urethral 0 2000 IU QD
125255001 12525500 12 C COENZYME Q-10 2 Unknown 0 200 MG QD
125255001 12525500 13 C CETIRIZINE HCL CETIRIZINE HYDROCHLORIDE 1 Unknown 0 10 MG QD
125255001 12525500 14 C BIOTIN BIOTIN 1 Unknown 0 1000 UG QD
125255001 12525500 15 C BAYER LOW DOSE ASPIRIN 2 Unknown 0 81 MG QD
125255001 12525500 16 C VITAMIN B12 CYANOCOBALAMIN 1 Unknown 0 2500 UG QD
125255001 12525500 17 C ATORVASTATIN CALCIUM. ATORVASTATIN CALCIUM 1 Unknown 0 20 MG QD
125255001 12525500 18 C LEVOTHROID LEVOTHYROXINE SODIUM 1 Unknown 0 100 UG QD

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
125255001 12525500 1 Type 2 diabetes mellitus
125255001 12525500 3 Arrhythmia
125255001 12525500 4 Arrhythmia
125255001 12525500 6 Antidepressant therapy
125255001 12525500 7 Diabetes mellitus
125255001 12525500 8 Multiple allergies
125255001 12525500 9 Diabetes mellitus
125255001 12525500 13 Hypersensitivity
125255001 12525500 18 Thyroid therapy

Outcome of event

no results found

Reactions reported

Event ID CASEID DRUG REC ACT PT
125255001 12525500 Body height decreased
125255001 12525500 Heart rate irregular
125255001 12525500 Intentional product misuse
125255001 12525500 Product quality issue
125255001 12525500 Weight decreased

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
125255001 12525500 1 2005 0
125255001 12525500 3 201606 0
125255001 12525500 4 201606 0
125255001 12525500 7 2004 0